Markets:

Overview

News

Currencies

International

Treasuries

Aquestive Therapeutics, Inc. - Common Stock (NQ:AQST)

3.910 -2.300 (-37.04%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aquestive Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

What's going on in today's session ↗

January 09, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Friday's session. ↗

January 09, 2026

Via Chartmill

The market is filled with gapping stocks in Friday's session. ↗

January 09, 2026

Via Chartmill

Friday's pre-market session: top gainers and losers ↗

January 09, 2026

Via Chartmill

Why Did AQST Stock Plunge 40% In Pre-Market Today? ↗

January 09, 2026

Via Stocktwits

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Aquestive Stock Jumps After-Hours As CEO Sees $1B ‘Blockbuster’ Potential For Oral Allergy Film — Retail Sees Stock As Buyout Candidate ↗

September 26, 2025

Via Stocktwits

FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film ↗

September 04, 2025

Via Stocktwits

Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles

January 08, 2026

In a dramatic shift that has recalibrated the pulse of Wall Street, the Russell 2000 index (RUT) surged to a new record high on January 8, 2026, signaling a definitive breakout for small-cap stocks. As...

Via MarketMinute

Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears

January 07, 2026

The Russell 2000 index, the primary benchmark for American small-cap stocks, suffered a significant sell-off on Wednesday, January 7, 2026, as a batch of conflicting economic data sparked fears that...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail ↗

August 14, 2025

Via Stocktwits

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Jim Cramer: Joby Is 'Losing Too Much Money' ↗

November 12, 2025

Jim Cramer finds Aquestive Therapeutics very interesting, while Amphenol Corporation is a great stock. Joby Aviation is losing money.

Via Benzinga

Friday's session: gap up and gap down stocks ↗

September 26, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday ↗

September 26, 2025

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA...

Via Benzinga

Topics Stocks

ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment ↗

September 23, 2025

ARS Pharmaceuticals petitioned the FDA to delay approval of Aquestive's epinephrine film, citing safety, dosing, and cardiovascular concerns.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 19, 2025

Via Benzinga

CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday ↗

September 19, 2025

Via Benzinga

Which stocks are gapping on Friday? ↗

September 19, 2025

The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 04, 2025

Via Benzinga

Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday ↗

September 04, 2025

Via Benzinga

FDA Confirms Direct Review Path For Aquestive's Allergy Treatment ↗

September 04, 2025

Aquestive's Anaphylm could become the first oral epinephrine for severe allergic reactions after the FDA set a 2026 decision date without panel review.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 04, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 14, 2025

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Uncovering Potential: Aquestive Therapeutics's Earnings Preview ↗

August 08, 2025

Via Benzinga

Uncovering Potential: Aquestive Therapeutics's Earnings Preview ↗

May 09, 2025

Via Benzinga

Aquestive Therapeutics Concludes FDA Application For Allergy Drug With Encouraging Pediatric Trial Data ↗

April 01, 2025

Aquestive's Anaphylm sublingual film met key pediatric study goals, supporting its NDA submission to the FDA for potential approval in 2025.

Via Benzinga

Aquestive Therapeutics Stock Dips After-Hours On Q4 Miss — Retail Eyes Silver Linings ↗

March 05, 2025

Stocktwits users are viewing the company's cash position, expectations for a late 2026 Anaphylm launch, and an upcoming trial as positive signals.

Via Stocktwits

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

March 05, 2025

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.